Aims LOX-1 is a major vascular receptor for oxidized low-density lipoprotein (oxLDL). In this study, we analysed the impact of LOX-1 overexpression and high dietary fat intake on vascular function in small resistance arteries. Methods and results Relaxation of mesenteric arteries was measured using a wire myograph. Compared with the control group, mice overexpressing LOX-1 on a high-fat diet (FD) had preserved vascular smooth muscle relaxation, but impaired endothelium-dependent relaxation via NO. Vascular NO availability was decreased by exaggerated formation of reactive oxygen species and decreased endothelial NO synthase expression. Endothelium-derived hyperpolarizing factor (EDHF)-mediated relaxation via cytochrome P450 metabolites was increased in LOX-1 þ FD animals, but did not completely compensate for the loss of NO. Currents of calcium-activated potassium channels with large conductance (BK Ca channels) were measured by the voltage-clamp method. The BK Ca current amplitudes were not altered in endothelial cells, but highly increased in vascular smooth muscle cells from resistance arteries of LOX-1-overexpressing mice on FD. BK Ca currents were activated by low-dose H 2 O 2 and cytochrome P450 metabolites 11,12-EET and 14,15-EET as EDHF in control mice. Conclusion LOX-1 overexpression and FD caused functional changes in endothelial and vascular smooth muscle cells of small resistance arteries. 
Introduction
Atherosclerosis, with its clinical manifestation in cardiovascular diseases, is the major cause of death in industrialized countries. Functional changes in endothelial cells (ECs) and vascular smooth muscle cells (VSMCs) contribute to the initiation and early progression of cardiovascular diseases like atherosclerosis. [1] [2] [3] Resistance arteries do not show morphological alterations in response to high-fat diet (FD) or oxLDL, but rather develop functional impairment. 4 Several changes in the early phase of endothelial dysfunction are associated with high plasma levels of lipoproteins. Circulating low-density lipoproteins (LDL) can be modified to oxidized LDL (oxLDL). The major receptor of oxLDL is the lectin-like oxLDL receptor-1 (LOX-1) in the vessel wall. [5] [6] [7] LOX-1 mediates endocytosis of oxLDL in ECs, 8 VSMCs, and monocytes. 9 Basal LOX-1 expression is low, but several pathophysiological conditions like hypertension, diabetes mellitus, and hyperlipidaemia and the development of atherosclerotic lesions have been linked with an increased vascular LOX-1 expression. 10 The G501C mutation in the lectin-like oxidized LDL receptor gene (LOX-1/OLR1) has been associated with the risk of myocardial infarction, 11 but not with the risk for stroke. 12 LOX-1 expression is increased in human atherosclerotic lesions (in early lesions mainly in ECs, in advanced lesions also in VSMCs and macrophages). 13 Moreover plaque formation is enhanced in coronary arteries of mice overexpressing LOX-1 against a genetic background of apolipoprotein E deficiency.
14 Cell-culture studies have shown that the endothelial generation of reactive oxygen species (ROS) by NAD(P)H oxidase complexes in response to oxLDL is mediated by LOX-1. 15 Furthermore, in vitro studies indicate that activation of LOX-1 also initiates a reduction in NO release. 15 However, little is known about the contribution of LOX-1 to vascular homeostasis and endothelial dysfunction in small vessels. The intact endothelium plays an important role in vascular function by synthesizing and releasing vasodilating factors. 16 Major vasodilating factors in arteries are the endotheliumderived hyperpolarizing factor (EDHF), nitric oxide (NO), and prostacyclin. The reduced NO availability in atherosclerosis can be mediated via decreased expression of the endothelial NO synthase (eNOS) or via inactivation of NO by ROS. 2 In addition to eNOS expression, there is also evidence of reduced eNOS activity by lack of cofactors (e.g. BH 4 ) and increased formation of endogenous inhibitors. 17 The impaired NO-mediated relaxation in different vessels of hypercholesterolaemic and atherosclerotic animal models or patients 18, 19 can be compensated by EDHF. Several components for EDHF signalling have been proposed including electrical coupling through gap junctions, certain ROS as for instance H 2 O 2 , cytochrome P450 metabolites, and vascular Ca 2þ -activated K þ channels (K Ca ) 20 in particular those with large conductance (BK Ca channels). [21] [22] [23] Activation of BK Ca channels facilitates relaxation by cell membrane hyperpolarization. Nevertheless their role in endothelial and smooth muscle dysfunction is not completely understood. Binding of oxLDL to LOX-1 was shown to modulate BK Ca -channels in ECs in vitro.
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In this study, we have used mice overexpressing bovine LOX-1 that were fed an FD to examine a potential functional impairment of small resistance arteries (mesenteric arteries). Based on our experimental findings, we provide evidence that LOX-1 receptors can cause vascular dysfunction in resistance vessels.
Methods

Animals
Male wild-type mice (C57BL/6, WT) and mice overexpressing bovine LOX-1 in a C57BL/6 background under control of the murine preproendothelin-1 promoter (LOX-1 mice 14 ), aged 8 weeks, were fed standard chow EF R/M CD88137 or FD EF R/M TD88137 (Ssniff Spezialitäten GmbH, Soest, Germany) for 10 weeks. LOX-1 mice were kindly provided by T.S., Department of Vascular Physiology, National Cardiovascular Center Research Institute Fujishirodai, Suita, Osaka, Japan. The generation and characterization of the mice has been recently described by Inoue et al.
14 The LOX-1 mice carry 24 copies of the transgene, resulting in an approximately eight-fold higher mRNA-expression and a marked upregulation of endothelial LOX-1 protein expression. A similar upregulation of the LOX-1 protein has been described in ECs of human carotid arteries, covering early atherosclerotic lesions. 13 Overexpression of the bovine LOX-1 was verified by PCR in mesenteric arteries (see Supplementary material online, Figure S1 ). 
Serum lipid measurements
Serum lipids were measured at the Institute of Clinical Chemistry and Laboratory Medicine (University of Technology Dresden) using kits for triglycerides, cholesterol, HDLs and LDLs (Roche Diagnostics GmbH, Mannheim, Germany).
Preparation of mesenteric arteries for in vitro studies
Arteries (third-order branch) were dissected and maintained in Ca ) and NADPH (100 mmol/L) were dissolved in Krebs-Henseleit buffer for determination of ROS. Lucigenin solution containing additional 200 U/mL superoxide dismutase (SOD) and 380 U/mL catalase was used to examine superoxide anions and the resulting H 2 O 2 formation. 25 Solution without tissue served as control. Photoemission was detected every second for 30 min in a Fluorescence Microplate Reader Fluorimeter FLUOstar OPTIMA (BMG LABTECH, Jena, Germany). The length of the blood vessels was measured with an eye piece scale (ZEISS, Jena, Germany) and used for data normalization. The increase in ROS production in animals fed with an FD was normalized as 100% of the corresponding control.
Measurement of contractile function
Small sections of mesenteric arteries (length 2 mm) were mounted in microvascular myographs for isometric tension recordings as described previously 26 and maintained in oxygenated PSS (5% CO 2 in 95% O 2 ; 1.6 mmol/L CaCl 2 ) at 378C. During equilibration of the vessels, tension (T ) corresponding to a pressure (P) of 70 mm Hg according to the equation P ¼ T2pU 21 (U ¼ inner circumference) was adjusted. In all experiments cyclooxygenase-mediated relaxation was blocked with cyclooxygenase inhibitor diclofenac (0.1 mmol/L; Sigma, Taufkirchen, Germany). The vessel rings were contracted with cumulatively increasing concentrations of phenylephrine (PE). Relaxation was measured by increasing concentrations of acetylcholine (ACh) or sodium nitroprusside (SNP) in PE-precontracted (10 mmol/L) vessels. Relaxing effects of ACh were studied in the absence and presence of NO synthase inhibitor nitro-L-arginine-methylester (L-NAME; 30 mmol/L), BK Ca inhibitor paxilline (1 mmol/L), cytochrome P450 inhibitor N,N-diethylaminoethyl-2,2-diphenylvalerate (proadifen; 50 mmol/L), and epoxygenase inhibitor 6-(2-propargyloxyphenyl)hexanoic acid (PPOH; 30 mmol/L). The effects of ACh or SNP are expressed in percent of the response to PE (¼100%).
Isolation of vascular cells
Mesenteric arteries were stored in low Ca 
Electrophysiological experiments
Potassium outward current through the BK Ca channels (I BK,Ca ) was measured using a HEKA-EPC8 amplifier (HEKA Elektronik (11,12- EET; 300 nmol/L), and 14(R),15(S)-Epoxy-(5Z,8Z,11Z)-eicosatrienoic acid (14,15-EET; 300 nmol/L). The cell capacity was used for data normalization. Unless stated otherwise, all substances were purchased from Sigma, Taufkirchen, Germany.
RNA isolation and real-time PCR
Total RNA of mesenteric arteries was isolated using the EZNA Total RNA-Kit (Peqlab, Erlangen, Germany). For quantification of mRNA expression real-time PCR was performed using the QuantiTect SYBR Green RT-PCR kit (Qiagen, Hilden, Germany) in a thermal cycler (Corbett Research, Mortlake, Australia). Primers: bovine LOX-1 (sense:
, and KCNMB1 (sense: 5 0 -AGAAGCGCGGAGAGA CACGA-3 0 , antisense: 5 0 -CAGCTCTTCCTGGTCCTTGATA-3 0 ). Quantification by one-step RT real-time PCR included 508C for 30 min, 958C for 15 min, subsequent cycles of 948C for 30 s, 608C for 30 s, and finally 728C for 50 s. Internal RNA standards were produced as previously described. 27 
Data analysis and statistics
Potency of agonists was determined as 2logEC 50 [mmol/L]. All results are expressed as mean+standard error of the mean (SEM). Unless stated otherwise, number of experiments is given as arteries or cells from n mice. Student's t-test (unpaired) was used for statistical analysis, differences with P , 0.05 were considered significant. Multiple comparisons were done by one-way ANOVA followed by Bonferroni post hoc test. Table 1 summarizes body weight and serum lipid concentrations in the four investigated animal groups. LOX-1 mice on normal diet were heavier than WT mice, but did not differ in serum lipid concentrations. FD significantly increased body weight in WT and in transgenic mice when compared with control diet. While serum concentrations of triglycerides were not different between the groups, free cholesterol, LDL, and HDL concentrations were significantly higher in WT and LOX-1 animals on high-fat compared with standard diet. The ratio of LDL:HDL increased during FD from 1:7 to 1:4 in WT mice and from 1:8 to 1:4 in LOX-1 mice. Although FD caused significantly larger weight gain in LOX-1 mice compared with WT animals, no statistically significant differences were found in serum lipid parameters.
Results
Body weight and serum lipids
Vascular function
Basal tone of mesenteric arteries was unaffected by FD (compare pre-PE control values in Supplementary material online, Figure S2A ).
Endothelium-dependent and -independent relaxation in mesenteric arteries was studied in PE-preconstricted vessels. In order to determine the optimum concentration for precontraction, we measured contractile responses to cumulatively increasing PE concentrations. All vessels contracted in the same concentration range [average 2logEC 50 Figure S2A ). Subsequently, arteries in all further experiments were precontracted with 10 mmol/L PE. Values of maximum contraction produced by 80 mmol/L KCl were similar in the four groups (see Supplementary material online, Figure S2C ). Absolute values of the constriction induced by 100 mM PE and 80 mmol/L KCl in WT and LOX-1 mice are consistent with previously published results. 28, 29 Endothelium-dependent relaxation was studied by exposing the arteries to increasing concentrations of ACh. The resulting concentration-response curves (CRC; Figure 1A and B) revealed incomplete relaxation by ACh with significantly reduced relaxation in LOX-1 þ FD animals (maximum relaxation, Eff max : 67.8 + 3.4%; P , 0.01) compared with WT, WT þ FD, and LOX-1 (Eff max : 89.3 + 5.0%; 88.1 + 4.7%; and 88.1 + 3.6%; Figure 1C ). Interestingly, potencies were similar in all groups [average 2logEC 50 (mol/L) values between 6.8 and 7.0]. The relaxing response to ACh was reduced in the presence of the NO synthase (NOS) blocker L-NAME (30 mmol/L). Relaxation was reduced in WT (42.2 + 5.6%), WT þ FD (39.1 + 7.5%), and LOX-1 mice (40.1 + 6.1%), but not in LOX-1 þ FD arteries (5.5 + 5.2%). These results suggest that NO-mediated relaxation was significantly impaired in LOX-1 þ FD animals compared with the other groups ( Figure 1D ). In addition the basal tone during L-NAME incubation increased only in arteries from WT, WT þ FD, and LOX-1 animals, but not in LOX-1 þ FD mice. In the presence of L-NAME, the differences in PE-induced contractions between LOX-1 þ FD mice and the other three animal groups persisted (see Supplementary material online, Figure S2D and E). ACh-induced relaxation in the presence of NOS and cyclooxygenase inhibitors is mediated by EDHF. The EDHFmediated fraction of relaxation was largest in LOX-1 þ FD mice (62.6 + 3.5%) compared with the other groups (WT: 47.0 + 3.2%; WT þ FD: 49.0 + 4.0%; LOX-1: 48.0 + 4.1%; P , 0.01; Figure 1E ). Cytochrome P450 enzymes are a substantial source of EDHF, they are responsible for the transformation of arachidonic acid into epoxyeicosatrienoic acids (EETs). 30, 31 The role of these enzymes in ACh-induced relaxation was examined with proadifen, a non-specific blocker of cytochrome P450 isoenzymes and PPOH, a specific epoxygenase blocker. Proadifen and PPOH did not significantly block EDHF-mediated relaxation in WT, WT þ FD, and LOX-1 animals, but significantly reduced EDHF-mediated relaxation in LOX-1 þ FD (proadifen 41.3 + 6.3%; P , 0.01 and PPOH 28.7 + 6.3%; P , 0.05; Figure 2A-D) . Both compounds changed the efficacy of ACh to a larger extent in LOX-1 þ FD mice compared with the other groups, leading to similar levels of relaxation in all four groups.
The contribution of BK Ca channels as potential EDHF targets in LOX-1 þ FD was tested by blocking the channels with the specific BK Ca blocker paxilline ( Figure 2E-H ) . Paxilline reduced ACh-mediated relaxation only in LOX-1 þ FD (18.42 + 3.6%; P ¼ 0.0026), but not in WT (0.1 + 3.3%), WT þ FD (1.6 + 2.5%), and LOX-1 animals (1.1 + 3.9%), indicating that BK Ca channels were activated only in LOX-1 þ FD mice. Even in the presence of L-NAME, paxilline was able to inhibit relaxation, indicating a BK Ca channel involvement in the EDHF-mediated relaxation. During paxilline incubation the basal tone significantly elevated in arteries from LOX-1 þ FD mice compared with WT, WT þ FD, and LOX-1 animals (see Supplementary material online, Figure S2F ). PE-induced contraction in the presence of paxilline was similar in all four groups (see Supplementary material online, Figure S2G ).
Endothelium-independent relaxation was measured using the NO-donor SNP. Potency and efficacy of SNP were calculated from cumulative CRCs (see Supplementary material online, Figure S3 ) and were found to be similar in all groups [2logEC 50 
Reactive oxygen species
Since vascular dysfunction is associated with increased ROS production, we have examined the formation of ROS by chemiluminescence in mesenteric arteries. ROS formation was increased in WT þ FD and LOX-1 þ FD, and the increase Figure 1 Effects of acetylcholine in mesenteric arteries of WT and LOX-1 mice. (A) Concentration-response curves (CRCs) for acetylcholine in arteries of WT mice on standard and high-fat diet without and with L-NAME. (B) CRCs for acetylcholine in arteries of LOX-1 mice on standard and high-fat diet without and with L-NAME. Maximum effects of acetylcholine-induced (C ), NO-mediated relaxation (D), and EDHF-mediated relaxations (E) of arteries from WT and LOX-1 mice on standard and high-fat diet. ***P , 0.001 control vs. L-NAME of mice on standard diet. ### P , 0.001 control vs. L-NAME of mice on high-fat diet. Figure 2 Concentration-response curve for acetylcholine in the presence of BK Ca channel blocker and cytochrome P450 blocker in mesenteric arteries of WT and LOX-1 mice. Concentration-response curves (CRCs) for acetylcholine in the presence of cytochrome P450 blocker proadifen and epoxygenase blocker PPOH in arteries of (A) WT; (B) WT þ FD; (C ) LOX-1; (D) LOX-1 þ FD in combination with L-NAME. CRCs for acetylcholine in the presence of BK Ca -channel blocker paxilline on the arteries of (E) WT; (F ) WT þ FD; (G) LOX-1, and (H ) LOX-1 þ FD and in the presence and absence of L-NAME. *P , 0.05 proadifen þ L-NAME vs. L-NAME; **P , 0.01 PPOH þ L-NAME vs. L-NAME.
was even higher in LOX-1 þ FD than in WT þ FD animals (see Supplementary material online, Figure S4 ). We have also determined superoxide anions, because this particular fraction of ROS has been previously shown to result in H 2 O 2 formation and act directly as an EDHF component. 32 We found that H 2 O 2 levels were significantly increased in LOX-1 þ FD mice (56.2 + 5.8%) compared with the other groups (WT: 33.2 + 3.4%; WT þ FD: 40.6 + 8.3%; LOX-1: 39.8 + 5.7%; see Supplementary material online, Figure S4 ).
BK Ca currents
Our results provide evidence that EDHF formation is involved in the contractile responses and that EDHF has the largest impact in the LOX-1 þ FD group. Since EDHF activates BK Ca channels, we measured BK Ca currents in smooth muscle and ECs in order to elucidate their contribution to the observed EDHF-mediated response in LOX-1 þ FD mice.
All VSMCs exhibited robust BK Ca currents. The current amplitude was completely suppressed by the selective BK Ca channel-blocker paxilline (1 mmol/L). 33 Current densities of I BK,Ca in VSMCs at a test potential of þ60 mV were significantly higher in LOX-1 þ FD mice (623 + 93 pA/pF) compared with WT (356 + 54 pA/pF), WT þ FD (346 + 47 pA/pF), and LOX-1 (324 + 54 pA/pF; Figure 3A and B). In LOX-1 þ FD I BK,Ca voltage dependence was shifted to lower voltages suggesting that the current is already activated at more negative potentials. Moreover, opening of BK Cachannels with the selective channel activator NS1619 (30 mmol/L) 34 did not further increase current density in LOX-1 þ FD mice, but increased the current in the other groups to almost the same levels as previously observed in LOX-1 þ FD ( Figure 3C) . Interestingly, the I BK,Ca current densities in ECs were similar in all four mice groups (WT: 64 + 31 pA/pF; WT þ FD: 61 + 12 pA/pF; LOX-1: 63 + 27 pA/pF; LOX-1 þ FD: 68 + 32 pA/pF), but much smaller than in VSMCs ( Figure 3D and E) . Next, we examined the effects of three supposed EDHFs, i.e. H 2 O 2 , 11,12-EET, and 14,15-EET, on BK Ca channel activity in WT mice. At þ 60 mV H 2 O 2 (1 mmol/L) significantly increased current density, but not to the same value as observed with NS1619 or in LOX-1 þ FD mice. 11,12-EET and 14,15-EET (300 nmol/L each) activated I BK,Ca to the same maximum as NS1619 ( Figure 4A-C) in WT mice and as the observed amplitude in LOX-1 þ FD animals.
mRNA expression of BK Ca channel subunits and eNOS
Differences in current densities could be due to different expression levels of the relevant channel subunits. Therefore, we have measured mRNA expression of the BK Cachannels using real-time PCR (Figure 5A and B) . Both the pore-forming a-subunits and the accessory b1-subunits were expressed in similar amounts in all groups. In contrast mRNA expression of eNOS was lower in LOX-1 þ FD mice compared with WT, WT þ FD, and LOX-1 animals ( Figure 5C ). This finding is in agreement with the reduced NO-dependent vascular relaxation in this group of animals. In heart and kidney, we did not detect statistically significant differences in the mRNA and protein expression of the BK Ca channel a-and b1-subunits and eNOS between all groups.
Discussion
The main findings of our study show that mice overexpressing the LOX-1 in combination with FD have markedly increased body weight, display impaired NO-mediated, and enhanced EDHF-dependent relaxation in mesenteric arteries, and have increased vascular ROS production in LOX-1 þ FD compared with WT þ FD animals. Furthermore, BK Ca channel activity in VSMCs was higher in LOX-1 þ FD, which could be increased by the EDHFs H 2 O 2 and EETs. In contrast, endothelial BK Ca channel activity was unchanged.
Body weight and plasma lipids
As expected, WT and LOX-1 overexpressing mice gained weight after FD. However, LOX-1 mice on standard diet were also heavier than their corresponding WT animals suggesting an impact of LOX-1 on weight control or metabolic status. Higher body weight in LOX-1 mice was not associated with a significant shift in plasma lipid parameters to a more harmful lipid profile as observed with FD in both WT and LOX-1 mice. In the latter two groups, elevated total plasma cholesterol, LDL, and HDL are in agreement with previous studies. 35, 36 Furthermore the LDL/HDL quotient shifted to higher values suggesting an enhanced risk for endothelial dysfunction and atherosclerosis. 37 
Vascular constriction and relaxation
None of the animals had grossly visible atherosclerotic lesions. Therefore, we tested for vascular dysfunction as an early sign of cardiovascular disease by measuring contraction and endothelium-dependent as well as endothelium-independent relaxation of PE-preconstricted small resistance arterioles. The impact of oxLDL on vascular tone is not fully resolved. OxLDL enhances the basal tone in rabbit cerebral arteries. 38 In contrast, oxLDL has no effect on basal tone in rabbit aorta. 39 We observed no differences in basal vascular tone in the animal groups fed standard or FD. However, the maximum contractile response to PE was lower in LOX-1 þ FD than in the other animals, but potencies were similar. This difference in the vessel contraction between LOX-1 þ FD mice and the other three animal groups was not observed in the presence of high, depolarizing potassium concentration or by the combination of PE and paxilline, suggesting a mechanism that involves potassium channel activity. BK Ca channels also participate in ACh-/ endothelium-mediated relaxation. [21] [22] [23] ACh-stimulated, NO-mediated dilatation was lower in LOX-1 þ FD mice than in WT, WT þ FD, and LOX-1 animals, suggesting reduced NO availability in LOX-1 þ FD. In accordance basal tone during L-NAME incubation was less increased in LOX-1 þ FD mice compared with WT, WT þ FD, and LOX-1 animals. Effectivity of L-NAME to eliminate NO production has been questioned because in some species, especially in pig and rabbit, endothelium-dependent/NO-mediated relaxation was resistant to eNOS-inhibitors. 40 In our experiments with mouse mesenteric arteries, however, relaxation persisting after inhibition of eNOS with L-NAME was fully suppressed with apamin and charybdotoxin, the combination of which is commonly used for EDHF block (data not shown). Possible explanations for decreased NO-mediated relaxation in mesenteric arteries of LOX-1 þ FD mice are (i) that ROS production is elevated, (ii) that expression of eNOS mRNA is reduced, and (iii) that EDHF can compensate for the loss of NO. 41 In contrast to the reduced NO-mediated relaxation, the EDHF-dependent response was elevated in LOX-1 þ FD mice compared with WT, WT þ FD, and LOX-1 animals, but could be abolished by a general cytochrome P450 blocker or by an epoxygenase inhibitor. This finding suggests a potential role of cytochrome P450 and its epoxygenases as a compensatory mechanism that makes up for the loss of NO and subsequent endothelial dysfunction in LOX-1 þ FD mice. This same amount of EDHF, which was abolished by the cytochrome P450 inhibitors, was also blocked by paxilline in the presence and absence of L-NAME suggesting an essential role of the BK Ca channel in the EDHF-mediated relaxation. Block of cytochrome P450 or BK Ca channels in LOX-1 þ FD led to similar levels of persisting EDHF-mediated relaxation in all four groups. The nature of the persisting EDHF-mediated relaxation was not investigated in this study. As reported before, release of EDHF from ECs is associated with the endothelial activity of calcium-activated potassium channels of small and intermediate conductance, 21 but the activation of BK Ca channels is involved in the EDHF-mediated relaxation of VSMCs. No relevant differences in endothelium-independent relaxation were detected, i.e. potency and efficacy of SNP were similar in all groups, suggesting comparable properties of VSMC-relaxation in mice on FD and standard diet. Interestingly, an EETs-mediated relaxation in response to 11,12-EET and 14,15-EET was significantly increased in mesenteric arteries with and without endothelium of LOX-1 þ FD mice compared with WT, WT þ FD, and LOX-1 animals (see Supplementary material online, Figure S5 ). This could be mediated by the compensatory enhanced activity of the BK Ca channels in VSMCs of LOX-1 þ FD mice. However, activation is not sufficient to compensate for the loss of NO in the LOX-1 þ FD mice.
Vascular reactive oxygen species productions
Our results and several previous studies have shown that hypercholesterolaemia is associated with impaired endothelium-dependent relaxation in experimental and clinical studies. 1, [42] [43] [44] Rapid degradation of endotheliumderived NO by high levels of ROS is thought to be a major mechanism underlying impaired endothelium-dependent vasodilatation under hypercholesterolaemic conditions. It should also be responsible for decreased endotheliumdependent relaxation. 45, 46 In our experiments, ROS was indeed increased in LOX-1 þ FD and WT þ FD mice, and to a larger extent in the former than the latter. ROS leads to oxidation of LDL resulting in increased oxLDL levels. Uptake of oxLDL via LOX-1 into ECs activates NAD(P)H oxidases and enhances production of ROS, 47, 48 starting a vicious cycle finally leading to endothelial dysfunction. However, exaggerated ROS production has not only deleterious effects. Growing evidence supports an import role of redox-sensitive signalling in vascular function. 49 Furthermore Shimokawa and Matoba 32 have suggested that the ROS product H 2 O 2 could act as EDHF. H 2 O 2 amount was higher in LOX-1 þ FD mice than in WT, WT þ FD, and LOX-1 animals, suggesting a potential role in the elevated EDHF-mediated relaxation.
Role of endothelium-derived hyperpolarizing factor and BK Ca channel activity
In contrast to reduced NO-mediated responses, EDHFmediated relaxation was most pronounced in LOX-1 þ FD mice suggesting that this mechanism might partly compensate the impaired NO-mediated relaxation. Since different EDHFs, like EETs and H 2 O 2 are known to activate BK Ca channels in VSMCs, 21 we studied BK Ca currents directly. At any activating potential, the amplitude of I BK,Ca was indeed larger in VSMCs from LOX-1 þ FD than in the other groups. Moreover, I BK,Ca amplitude in LOX-1 þ FD mice could not be further increased by the BK Ca channel opener NS1619, suggesting that increased current amplitude resulted from enhanced channel open probability. This interpretation is supported by the fact that mRNA expression of the BK Ca channel a-and b1-subunits was similar in all mice. Because of the limited availability of vascular tissue from the mesenteric arteries, no additional data on protein level could be obtained. However, similar mRNA and protein expression of BK Ca channels have been demonstrated in human arteries and veins. 50 The I BK,Ca amplitudes in ECs were smaller than in VSMCs and did not reveal any differences between the four groups. Therefore BK Ca channels in ECs do not contribute to vascular dysfunction in LOX-1 þ FD mice. The activation of endothelial BK Cachannels contributes to the EDHF-mediated relaxation. Endothelial hyperpolarization can be transmitted directly via gap junctions to the VSMCs. 51, 52 In addition, the K þ outward current through BK Ca channels increases the extracellular potassium concentration. 53 The subsequent activation of the inward-rectifier potassium channel (K IR ) and the Na þ /K þ pump overcomes the minor depolarizing effects linked to the K þ increase 54, 55 and relaxes smooth muscle cells.
The possible EDHF H 2 O 2 significantly increased I BK,Ca in VSMCs, although the level did not reach the maximum current amplitude of NS1619 or as in LOX-1 þ FD mice. Therefore, H 2 O 2 plays only a minor compensatory role in EDHF-mediated relaxation of this model. Recently, an inhibiting effect of H 2 O 2 on cytochrome P450 has been suggested, indicating a negative feedback mechanism of EET production. 56 This could not be confirmed in our experimental model.
Reduced NO levels have been reported to disinhibit cytochrome P450 and hence elevate two other possible EDHF components, 11,12-EET and 14,15-EET. [57] [58] [59] These two EETs were able to enhance I BK,Ca to similar maximum current amplitude as observed in the presence of NS1619 and in LOX-1 þ FD. In agreement with previous findings in isolated renal arteries of hypercholesterolaemic rabbits, 18, 19 we suggest that enhanced formation of EDHF represents a compensatory mechanism of the decreased NO-mediated vessel relaxation. In contrast, UrakamiHarasawa et al. 60 found a significant inhibition of endothelium-dependent hyperpolarization in isolated gastroepiploic arteries from atherosclerotic patients. These contradictory results could be explained by the longer duration of hypercholesterolaemic conditions and the progressive development of vascular diseases.
In the last few years, vascular BK Ca channels were considered as potential therapeutic targets in the treatment of hypertension, endothelial dysfunction, and other cardiovascular diseases, 61 because aldosterone overexpression induces a nitric-oxide-independent coronary dysfunction with decreased VSMC BK Ca expression and coronary BK Cadependent relaxation. 62 However activation of LOX-1 in clinical manifestation of atherosclerosis could activate VSMC BK Ca channels. In contrast, enhanced LOX-1 expression does not influence endothelial BK Ca channels.
In conclusion, we have consistently detected significant changes in contractile and electrophysiological properties of small resistance vessels only in the combination of LOX-1 overexpression and FD. The endothelium-mediated relaxation via NO release was impaired, but partly compensated by the higher release of EDHF. The consequence of this compensatory mechanism was a higher I BK,Ca due to increased open probability of BK Ca channels in VSMCs, but not in ECs. Our results clearly demonstrate that LOX-1 overexpression and FD cause functional changes in ECs and VSMCs of small resistance arteries leading to vascular dysfunction as an early sign of cardiovascular diseases.
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